The role of Bordetella infections in patients with acute exacerbation of chronic bronchitis

Acute exacerbations of chronic bronchitis (AECB) are associated with a variety of viral and bacterial infectious agents, some of which are potentially preventable by immunization. Bordetella pertussis, which causes whooping cough, has not been studied in this context. We aimed to assess the role of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Infection 2005-02, Vol.33 (1), p.13-17
Hauptverfasser: Bonhoeffer, J, Bär, G, Riffelmann, M, Solèr, M, Heininger, U
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 17
container_issue 1
container_start_page 13
container_title Infection
container_volume 33
creator Bonhoeffer, J
Bär, G
Riffelmann, M
Solèr, M
Heininger, U
description Acute exacerbations of chronic bronchitis (AECB) are associated with a variety of viral and bacterial infectious agents, some of which are potentially preventable by immunization. Bordetella pertussis, which causes whooping cough, has not been studied in this context. We aimed to assess the role of Bordetella infections in patients with AECB. Patients with AECB, who presented to participating private practices in Basel, Switzerland, between October 2000 and June 2002, were evaluated by a standardized questionnaire, nasopharyngeal swabs for culture (Bordetella spp.), and PCR (Bordetella spp. and selected other respiratory pathogens) and paired blood samples for serologic diagnosis of Bordetella infection. A total of 26 patients (34-86 years of age) were recruited. All culture and PCR samples were negative. Serology revealed Bordetella infection in eight (31%) patients. Duration of cough was shorter in patients with Bordetella infection compared to those without Bordetella infection (mean 15 days vs 41 days, p = 0.04). Cough > or = 21 days duration was present in three (43%) of seven patients with evidence of Bordetella infection compared to 17 (94%) of 18 controls (p = 0.012). Progression to convalescence from initial to follow-up visit after 4-6 weeks was comparable between both groups. Bordetella infections appear to play a significant role in AECB and preventive measurements such as immunization with acellular pertussis vaccines should be considered. Extended investigations are necessary to confirm our preliminary and provocative findings.
doi_str_mv 10.1007/s15010-005-4004-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67487906</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67487906</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-36b65fe7d6c0d0d539a3ebce470f38c0eb3656abd75d88b97501e93e8fcca4143</originalsourceid><addsrcrecordid>eNqFkb1PwzAQxS0EgvLxB7Agi4EtcK5jOxmh4ktCYikTg-U4F9VVGxfbEfDf46iVkFiY7obfPb13j5BzBtcMQN1EJoBBASCKEqAs6j0yYSWvC6gV3ycT4ABFxabyiBzHuIQM1qU6JEdMKAFKlBPyPl8gDX6F1Hf0zocWE65Whrq-Q5uc72Ne6cYkh32K9NOlBTV2SEjxy1gMjRmh8dgugu-dpU0eduGSi6fkoDOriGe7eULeHu7ns6fi5fXxeXb7UtjsOhVcNlJ0qFppoYVW8NpwbCyWCjpeWcCGSyFN0yrRVlVTZ-sMa45VZ60pc94TcrXV3QT_MWBMeu2iHWP06IeopSorVYP8F2SqktP8vwxe_gGXfgh9DqGnTEiWPY5qbAvZ4GMM2OlNcGsTvjUDPfajt_3o_HY99qNH4Yud8NCssf292BXCfwDvlot2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>215615396</pqid></control><display><type>article</type><title>The role of Bordetella infections in patients with acute exacerbation of chronic bronchitis</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Bonhoeffer, J ; Bär, G ; Riffelmann, M ; Solèr, M ; Heininger, U</creator><creatorcontrib>Bonhoeffer, J ; Bär, G ; Riffelmann, M ; Solèr, M ; Heininger, U</creatorcontrib><description>Acute exacerbations of chronic bronchitis (AECB) are associated with a variety of viral and bacterial infectious agents, some of which are potentially preventable by immunization. Bordetella pertussis, which causes whooping cough, has not been studied in this context. We aimed to assess the role of Bordetella infections in patients with AECB. Patients with AECB, who presented to participating private practices in Basel, Switzerland, between October 2000 and June 2002, were evaluated by a standardized questionnaire, nasopharyngeal swabs for culture (Bordetella spp.), and PCR (Bordetella spp. and selected other respiratory pathogens) and paired blood samples for serologic diagnosis of Bordetella infection. A total of 26 patients (34-86 years of age) were recruited. All culture and PCR samples were negative. Serology revealed Bordetella infection in eight (31%) patients. Duration of cough was shorter in patients with Bordetella infection compared to those without Bordetella infection (mean 15 days vs 41 days, p = 0.04). Cough &gt; or = 21 days duration was present in three (43%) of seven patients with evidence of Bordetella infection compared to 17 (94%) of 18 controls (p = 0.012). Progression to convalescence from initial to follow-up visit after 4-6 weeks was comparable between both groups. Bordetella infections appear to play a significant role in AECB and preventive measurements such as immunization with acellular pertussis vaccines should be considered. Extended investigations are necessary to confirm our preliminary and provocative findings.</description><identifier>ISSN: 0300-8126</identifier><identifier>EISSN: 1439-0973</identifier><identifier>DOI: 10.1007/s15010-005-4004-9</identifier><identifier>PMID: 15750754</identifier><language>eng</language><publisher>Germany: Springer Nature B.V</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Bordetella Infections - diagnosis ; Bordetella Infections - epidemiology ; Bordetella parapertussis ; Bordetella pertussis ; Bronchitis, Chronic - complications ; Bronchitis, Chronic - microbiology ; Female ; Humans ; Immunization ; Male ; Middle Aged ; Whooping Cough - diagnosis ; Whooping Cough - epidemiology</subject><ispartof>Infection, 2005-02, Vol.33 (1), p.13-17</ispartof><rights>Urban &amp; Vogel Medien und Medizin Verlagsgesellschaft 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-36b65fe7d6c0d0d539a3ebce470f38c0eb3656abd75d88b97501e93e8fcca4143</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15750754$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bonhoeffer, J</creatorcontrib><creatorcontrib>Bär, G</creatorcontrib><creatorcontrib>Riffelmann, M</creatorcontrib><creatorcontrib>Solèr, M</creatorcontrib><creatorcontrib>Heininger, U</creatorcontrib><title>The role of Bordetella infections in patients with acute exacerbation of chronic bronchitis</title><title>Infection</title><addtitle>Infection</addtitle><description>Acute exacerbations of chronic bronchitis (AECB) are associated with a variety of viral and bacterial infectious agents, some of which are potentially preventable by immunization. Bordetella pertussis, which causes whooping cough, has not been studied in this context. We aimed to assess the role of Bordetella infections in patients with AECB. Patients with AECB, who presented to participating private practices in Basel, Switzerland, between October 2000 and June 2002, were evaluated by a standardized questionnaire, nasopharyngeal swabs for culture (Bordetella spp.), and PCR (Bordetella spp. and selected other respiratory pathogens) and paired blood samples for serologic diagnosis of Bordetella infection. A total of 26 patients (34-86 years of age) were recruited. All culture and PCR samples were negative. Serology revealed Bordetella infection in eight (31%) patients. Duration of cough was shorter in patients with Bordetella infection compared to those without Bordetella infection (mean 15 days vs 41 days, p = 0.04). Cough &gt; or = 21 days duration was present in three (43%) of seven patients with evidence of Bordetella infection compared to 17 (94%) of 18 controls (p = 0.012). Progression to convalescence from initial to follow-up visit after 4-6 weeks was comparable between both groups. Bordetella infections appear to play a significant role in AECB and preventive measurements such as immunization with acellular pertussis vaccines should be considered. Extended investigations are necessary to confirm our preliminary and provocative findings.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Bordetella Infections - diagnosis</subject><subject>Bordetella Infections - epidemiology</subject><subject>Bordetella parapertussis</subject><subject>Bordetella pertussis</subject><subject>Bronchitis, Chronic - complications</subject><subject>Bronchitis, Chronic - microbiology</subject><subject>Female</subject><subject>Humans</subject><subject>Immunization</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Whooping Cough - diagnosis</subject><subject>Whooping Cough - epidemiology</subject><issn>0300-8126</issn><issn>1439-0973</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkb1PwzAQxS0EgvLxB7Agi4EtcK5jOxmh4ktCYikTg-U4F9VVGxfbEfDf46iVkFiY7obfPb13j5BzBtcMQN1EJoBBASCKEqAs6j0yYSWvC6gV3ycT4ABFxabyiBzHuIQM1qU6JEdMKAFKlBPyPl8gDX6F1Hf0zocWE65Whrq-Q5uc72Ne6cYkh32K9NOlBTV2SEjxy1gMjRmh8dgugu-dpU0eduGSi6fkoDOriGe7eULeHu7ns6fi5fXxeXb7UtjsOhVcNlJ0qFppoYVW8NpwbCyWCjpeWcCGSyFN0yrRVlVTZ-sMa45VZ60pc94TcrXV3QT_MWBMeu2iHWP06IeopSorVYP8F2SqktP8vwxe_gGXfgh9DqGnTEiWPY5qbAvZ4GMM2OlNcGsTvjUDPfajt_3o_HY99qNH4Yud8NCssf292BXCfwDvlot2</recordid><startdate>200502</startdate><enddate>200502</enddate><creator>Bonhoeffer, J</creator><creator>Bär, G</creator><creator>Riffelmann, M</creator><creator>Solèr, M</creator><creator>Heininger, U</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>200502</creationdate><title>The role of Bordetella infections in patients with acute exacerbation of chronic bronchitis</title><author>Bonhoeffer, J ; Bär, G ; Riffelmann, M ; Solèr, M ; Heininger, U</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-36b65fe7d6c0d0d539a3ebce470f38c0eb3656abd75d88b97501e93e8fcca4143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Bordetella Infections - diagnosis</topic><topic>Bordetella Infections - epidemiology</topic><topic>Bordetella parapertussis</topic><topic>Bordetella pertussis</topic><topic>Bronchitis, Chronic - complications</topic><topic>Bronchitis, Chronic - microbiology</topic><topic>Female</topic><topic>Humans</topic><topic>Immunization</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Whooping Cough - diagnosis</topic><topic>Whooping Cough - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bonhoeffer, J</creatorcontrib><creatorcontrib>Bär, G</creatorcontrib><creatorcontrib>Riffelmann, M</creatorcontrib><creatorcontrib>Solèr, M</creatorcontrib><creatorcontrib>Heininger, U</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bonhoeffer, J</au><au>Bär, G</au><au>Riffelmann, M</au><au>Solèr, M</au><au>Heininger, U</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of Bordetella infections in patients with acute exacerbation of chronic bronchitis</atitle><jtitle>Infection</jtitle><addtitle>Infection</addtitle><date>2005-02</date><risdate>2005</risdate><volume>33</volume><issue>1</issue><spage>13</spage><epage>17</epage><pages>13-17</pages><issn>0300-8126</issn><eissn>1439-0973</eissn><abstract>Acute exacerbations of chronic bronchitis (AECB) are associated with a variety of viral and bacterial infectious agents, some of which are potentially preventable by immunization. Bordetella pertussis, which causes whooping cough, has not been studied in this context. We aimed to assess the role of Bordetella infections in patients with AECB. Patients with AECB, who presented to participating private practices in Basel, Switzerland, between October 2000 and June 2002, were evaluated by a standardized questionnaire, nasopharyngeal swabs for culture (Bordetella spp.), and PCR (Bordetella spp. and selected other respiratory pathogens) and paired blood samples for serologic diagnosis of Bordetella infection. A total of 26 patients (34-86 years of age) were recruited. All culture and PCR samples were negative. Serology revealed Bordetella infection in eight (31%) patients. Duration of cough was shorter in patients with Bordetella infection compared to those without Bordetella infection (mean 15 days vs 41 days, p = 0.04). Cough &gt; or = 21 days duration was present in three (43%) of seven patients with evidence of Bordetella infection compared to 17 (94%) of 18 controls (p = 0.012). Progression to convalescence from initial to follow-up visit after 4-6 weeks was comparable between both groups. Bordetella infections appear to play a significant role in AECB and preventive measurements such as immunization with acellular pertussis vaccines should be considered. Extended investigations are necessary to confirm our preliminary and provocative findings.</abstract><cop>Germany</cop><pub>Springer Nature B.V</pub><pmid>15750754</pmid><doi>10.1007/s15010-005-4004-9</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0300-8126
ispartof Infection, 2005-02, Vol.33 (1), p.13-17
issn 0300-8126
1439-0973
language eng
recordid cdi_proquest_miscellaneous_67487906
source MEDLINE; SpringerLink Journals
subjects Adult
Aged
Aged, 80 and over
Bordetella Infections - diagnosis
Bordetella Infections - epidemiology
Bordetella parapertussis
Bordetella pertussis
Bronchitis, Chronic - complications
Bronchitis, Chronic - microbiology
Female
Humans
Immunization
Male
Middle Aged
Whooping Cough - diagnosis
Whooping Cough - epidemiology
title The role of Bordetella infections in patients with acute exacerbation of chronic bronchitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T03%3A05%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20Bordetella%20infections%20in%20patients%20with%20acute%20exacerbation%20of%20chronic%20bronchitis&rft.jtitle=Infection&rft.au=Bonhoeffer,%20J&rft.date=2005-02&rft.volume=33&rft.issue=1&rft.spage=13&rft.epage=17&rft.pages=13-17&rft.issn=0300-8126&rft.eissn=1439-0973&rft_id=info:doi/10.1007/s15010-005-4004-9&rft_dat=%3Cproquest_cross%3E67487906%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=215615396&rft_id=info:pmid/15750754&rfr_iscdi=true